Sable Announces Annual and Special Meeting of Shareholders
VANCOUVER, British Columbia, Aug. 15, 2024 (GLOBE NEWSWIRE) — Sable Resources Ltd. (“Sable” or the “Company”) (TSXV: SAE | OTCQB: […]
Annovis Bio Reports Second Quarter Financial Results and Provides Business Update
MALVERN, Pa., Aug. 15, 2024 (GLOBE NEWSWIRE) — via IBN — Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), […]
Solaris Reports 57m of 1.11% CuEq, 69m of 0.82% CuEq and 69m of 0.77% CuEq in Near Surface Results; Extends Mineralization North, Northwest and Southeast
VANCOUVER, British Columbia, Aug. 15, 2024 (GLOBE NEWSWIRE) — Solaris Resources Inc. (TSX: SLS; NYSE: SLSR) (“Solaris” or the “Company”) […]
Macerich Releases 2023 Corporate Responsibility Report
SANTA MONICA, Calif., Aug. 15, 2024 (GLOBE NEWSWIRE) — Macerich (NYSE: MAC), one of the nation’s leading owners, operators and […]
Brookfield Business Partners Announces Renewal of Normal Course Issuer Bids for Units and Exchangeable Shares
BROOKFIELD, News, Aug. 15, 2024 (GLOBE NEWSWIRE) — Brookfield Business Partners (NYSE: BBU, BBUC; TSX: BBU.UN, BBUC) today announced that […]
Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2024
Secured Medicare price assignment for theCompuFlo® Epidural System in multiple U.S. states Gross margin for the second quarter of 2024 […]
Traws Pharma Reports Q2 2024 Financial Results, Provides Recent Business Highlights
Merger with Trawsfynydd Therapeutics, Inc (“Trawsfynydd”) and concurrent private placement of $14 million (cash runway to support planned operations through […]
Dillard’s, Inc. Reports Second Quarter and Year-to-Date Results
LITTLE ROCK, Ark., Aug. 15, 2024 (GLOBE NEWSWIRE) — Dillard’s, Inc. (NYSE: DDS) (the “Company” or “Dillard’s”) announced operating results […]
Stantec selected by Los Angeles Department of Water & Power for 5-year US $104-million Master Services Agreement
LOS ANGELES and EDMONTON, Alberta and NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) — TSX, NYSE:STN Stantec, a global leader […]
BiomX Reports Second Quarter 2024 Financial Results and Provides Business and Program Updates
BiomX anticipates reporting important results in 2025 for two clinical assets from the Company’s leading phage therapy pipeline Recent stockholder […]
